Reuters - Video

エディション: US | UK | IN | CN | JP

video

FDA, EU diverge on AstraZeneca COVID-19 vaccine

2020年 10月 2日 Friday - 01:43

The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track. Conway G. Gittens reports.

▲ ストーリーを隠す

ストーリーを表示する

The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track. Conway G. Gittens reports.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

FDA, EU diverge on AstraZeneca COVID-19 vaccine

2020年 10月 2日 Friday - 01:43